Apellis Pharmaceuticals
APLS
APLS
95 hedge funds and large institutions have $423M invested in Apellis Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.2% more ownership
Funds ownership: 52.88% → 57.09% (+4.2%)
20% less capital invested
Capital invested by funds: $528M → $423M (-$105M)
Holders
95
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$23.6M | |
| 2 | +$11.6M | |
| 3 | +$9.31M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$4.35M |
| 5 |
O
OrbiMed
New York
|
+$4.31M |
Top Sellers
| 1 | -$29.4M | |
| 2 | -$16M | |
| 3 | -$6.6M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$6.33M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.95M |